Content about Diabetes mellitus

In November 2011, The Drug Store News Group hosted in New York an exclusive roundtable discussion of leading pharmacy retailers and a handful of key vendors.

GREENWICH, Conn. — Homeostasis Labs was named "Best New Product" by retail buyers attending the ECRM Home Health Care conference last month for a new sugar-free line of dietary supplements formulated to boost health for people with diabetes. 

BIRMINGHAM, Ala. — Novo Nordisk has launched a diabetes awareness sweepstakes in which the winners get a free trip to the 2013 IndyCar finale, the Danish drug maker said Friday.

The company announced that it had hired IZOD IndyCar Series Charlie Kimball as spokesman for its Race with Insulin contest. Kimball, the first licensed driver with diabetes to race at the highest level of the series, was diagnosed with the disease during a routine doctor visit in 2007 while racing in Europe and is a user of Novo Nordisk's NovoLog (insulin aspart [rDNA origin]).

NEW YORK — The American Diabetes Association, partnering with Walgreens and Duane Reade, on Tuesday kicked off its 25th Annual American Diabetes Association Alert Day, a one-day "wake-up call" asking the American public to take the Diabetes Risk Test to find out if they are at risk for developing Type 2 diabetes.   

BAGSVÆRD, Denmark — A drug made by Novo Nordisk for Type 2 diabetes produced a 6% loss of weight in a trial of the drug in obese patients, the company said.

The Danish drug maker announced results of a 56-week phase-3 trial to investigate the potential of Victoza (liraglutide) to produce and maintain weight loss in overweight and obese patients with Type 2 diabetes.

ALEXANDRIA, Va. — The cost of diabetes has increased by more than $70 billion over the past five years, according to new research from the American Diabetes Association.

The ADA announced the release of a report estimating that the total costs of diagnosed diabetes had risen 41%, from 2007's $174 billion to $245 billion in 2012. The report, Economic Costs of Diabetes in the U.S. in 2012, was commissioned by the ADA and addresses increased financial burden, health resources used and lost productivity associated with the disease.

NEW YORK — The YMCA is sponsoring a diabetes-control program that some say could slow the disease's spread, according to published reports.

PHILADELPHIA — While much of the attention to diabetes has focused on the dramatic rise of Type 2 diabetes among adults and children alike, a new study by a researcher in Philadelphia has found a spike in Type 1 diabetes among children as well.

NEW YORK — A nutritional supplement may help ward off gestational diabetes in pregnant women, according to a new study.

The study, conducted by researchers at Italy's University of Messina and published in the journal Diabetes Care, found that pregnant women with family histories of Type 2 diabetes who received myo-inositol saw a significant reduction in the incidence of gestational diabetes, a condition that causes high blood sugar in some pregnant women.

In August 2012, the American Association of Diabetes Educators highlighted recommendations and research confirming that more than one-third of the 25 million Americans with diabetes don’t take their insulin as prescribed, with 20% intentionally skipping doses and many admitting they inject it in the wrong place or at the wrong time or use the wrong technique, and only 30% of patients receive formal insulin education.

RARITAN, N.J. -- A panel of Food and Drug Administration experts has recommended approval for an experimental Type 2 diabetes drug made by Johnson & Johnson, the drug maker said.

J&J said the FDA's Endocrinologic and Metabolic Drugs Advisory Committee had recommended approval for canagliflozin, which the company plans to market under the name brand Invokana. The FDA is not required to follow the votes of advisory committees when deciding whether or not to approve a drug, but usually does.

CINCINNATI — Diabetes patients at Kroger pharmacies who have private insurance can pay $4 for blood-glucose test strips, the supermarket operator said.

Kroger said insured patients could pay a $4 co-pay for Kroger Premium test strips. People with diabetes can spend as much as $1,000 per year out of pocket on test strips alone, Kroger said.